Expression of Human β1 and β2 Adrenergic Receptors in E. Coli As a New Tool for Ligand Screening

Author:  ["Stefano Marullo","Colette Delavier-Klutchko","Jean-Gérard Guillet","Alain Charbit","Arthur Donny Strosberg","Laurent Jean Emorine"]

Publication:  Bio/Technology

CITE.CC academic search helps you expand the influence of your papers.

Tags:  general   Biotechnology   Biomedicine   general   Agriculture   BiomedicalEngi   Biological

Abstract

E. coli transformed with appropriate plasmid vectors express human β1 and β2-adrenergic receptors that retain the binding properties of the corresponding receptors in mammalian tissues. The experimental procedure required for pharmacological studies on active receptors expressed in bacteria is considerably simplified compared to that used for the same experiments in reference tissues. Moreover, in this bacterial system, receptor-binding assays display low background and high reproducibility. These advantages demonstrate that bacterial clones expressing membrane receptors constitute an alternative screening procedure for synthetic compounds specific for each β-adrenergic receptor subtype.

Cite this article

Marullo, S., Delavier-Klutchko, C., Guillet, JG. et al. Expression of Human β1 and β2 Adrenergic Receptors in E. Coli As a New Tool for Ligand Screening. Nat Biotechnol 7, 923–927 (1989). https://doi.org/10.1038/nbt0989-923

View full text

>> Full Text:   Expression of Human β1 and β2 Adrenergic Receptors in E. Coli As a New Tool for Ligand Screening

Recombinant Proteins of Therapeutic Interest Expressed by Lymphoid Cell Lines Derived from Transgeni

Enkephalins Prouduced in Transgenic Plants Using Modified 2S Seed Storage Proteins